PiB-PET used to explore brain changes

05/29/2013 | MedPage Today (free registration)

Buildup of beta-amyloid in the brain as measured through PiB-PET imaging appears to be linked to memory impairment and gray matter atrophy in cognitively normal adults, according to a subanalysis of the Australian Imaging, Biomarkers and Lifestyle Study of Aging published in JAMA Neurology. The results indicate PiB-PET imaging can be used to identify patients with cognitive impairment, according to the authors. "These findings support the notion that amyloid deposition is not a benign process and that interventions with anti-amyloid therapy at these early stages have a higher chance to be effective," researchers said.

View Full Article in:

MedPage Today (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Project Manager RA - 15000003MD
Abbott
Santa Clara, CA
Director, Site Quality Management
CareFusion
Minneapolis, MN
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
CT
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC